Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 2Patient Preference 1Diabetes Mellitus 1Coronary Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Risk Assessment × Clear all
NCT01468675 2017-04-28

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Brigham and Women's Hospital

Phase NA Completed
6,075 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Coronary Disease, Diabetes Mellitus, Colorectal Neoplasms

NCT01596582 2017-03-21

Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening

Boston Medical Center

Phase NA Completed
352 enrolled 19 charts
Gastrointestinal

Colorectal Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡